Cardiology

Hospital at Home and Heart Failure Care Equally Effective, But Clinician Judgment Most Important

George Padron
Specialty Medicine, Cardiology, Managed Care, Value Based Care | Jul 21, 2026
Kaiser's hospital-at-home program matched inpatient care on 30-day readmission, mortality, and GDMT in 307 matched heart failure pairs. Cost was not assessed.

Merck's Oral PCSK9 Inhibitor Approval Undercuts Injectables

George Padron
Specialty Medicine, Healthcare Headlines, FDA & Regulations, Cardiology, Access & Affordability, Prior Authorization, Managed Care, Formulary & Coverage, Pharmacy Benefit Trends | Jul 17, 2026
FDA has approved Lipfendra (enlicitide), the first oral PCSK9 inhibitor, priced at $315 per month. Merck has positioned it below injectable options, transitioning PCSK9 medications into retail pharmacies.

GLP-1 Drug Coverage for Type 1 Diabetes

Sonia Reyes
Cardiology, Endocrinology & Metabolic, Clinical Trial Updates | Jul 7, 2026
An emulated-trial study of 174,678 adults with type 1 diabetes links GLP-1 receptor agonist use to lower risks of major cardiac events and kidney failure.

New Guideline Addresses CKM Syndrome

Sonia Reyes
Specialty Medicine, Cardiology, Endocrinology & Metabolic | Jun 18, 2026
The 2026 AHA/ACC/ADA/ASN guideline reframes obesity, diabetes, kidney, and cardiovascular disease as one staged syndrome and ties treatment intensity to risk.

Art & Liz Still Discuss ATTR-CM Awareness

Sonia Reyes
Podcasts, Specialty Medicine, Cardiology | Jun 14, 2026
Art and Liz Still discuss their work raising awareness of hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) and their foundation, 'Still 4 Life.' In August 2023, Art was diagnosed with ATTR-CM, a rare genetic heart disease that is often overlooked and underdiagnosed by providers.